The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Adicet Bio, Inc. COM 007002108 9,311 662,676 SH   DFND 1 0 662,676 0
Aldeyra Therapeutics, Inc. COM 01438T106 4,081 594,834 SH   DFND 1 0 594,834 0
Arrowhead Pharmaceuticals COM 04280A100 250,206 3,260,869 SH   DFND 1 0 3,260,869 0
BiomX Inc. COM 09090D103 13,611 2,133,402 SH   DFND 1 0 2,133,402 0
Castlight Health Inc. CL B 14862Q100 1,055 811,295 SH   DFND 1 0 811,295 0
Catalyst Biosciences, Inc. COM 14888D208 422 66,951 SH   DFND 1 0 66,951 0
Fate Therapeutics, Inc. COM 31189P102 307,258 3,379,064 SH   DFND 1 0 3,379,064 0
Fusion Pharmaceuticals Inc. COM 36118A100 43,129 3,670,516 SH   DFND 1 0 3,670,516 0
Legend Biotech Corporation SPONSORED ADS 52490G102 45,878 1,629,173 SH   DFND 1 0 1,629,173 0
MeiraGTx Holdings plc COM G59665102 43,884 2,898,550 SH   DFND 1 0 2,898,550 0
PhaseBio Pharmaceuticals, Inc. COM 717224109 5,400 1,607,044 SH   DFND 1 0 1,607,044 0
Protagonist Therapeutics Inc. COM 74366E102 49,376 2,449,183 SH   DFND 1 0 2,449,183 0
Pulmonx Corp COM 745848101 389 5,639 SH   DFND 1 0 5,639 0
Senseonics Holdings, Inc. COM 81727U105 458 525,632 SH   DFND 1 0 525,632 0
Tracon Pharmaceuticals, Inc. COM 89237H209 983 84,003 SH   DFND 1 0 84,003 0